Understanding Trends In Rare Disease Drug Development
Let's dive into the details surrounding Trends In Rare Disease Drug Development. Every year, the last day of February marks
Key Takeaways about Trends In Rare Disease Drug Development
- Rachel Smith, Executive Director,
- There are over 7000
- Introducing the "
- Drug development
- C-Path's
Detailed Analysis of Trends In Rare Disease Drug Development
C-Path's Endpoints in Dr. Emily Morris, mathematical statistician at FDA's Center for
This video provides an introduction to how the patient voice is incorporated into regulatory decision making on
That wraps up our extensive overview of Trends In Rare Disease Drug Development.
